A comparison of prophylactic ondansetron hydrochloride and droperidol for strabismus repair in adults

Related Experiment Videos

E A Doe¹, P Jones, M A O'Hara

¹Department of Surgery, Brooke Army Medical Center, Fort Sam Houston, Texas 78234-6200, USA.

Journal of Pediatric Ophthalmology and Strabismus

|October 23, 1998

Abstract

Background:

Prophylactic administration of an antiemetic is a common procedure for patients undergoing strabismus surgery. Droperidol and ondansetron hydrochloride are commonly used antiemetics. This study compared the rates of postoperative nausea and vomiting (PONV) in adult patients undergoing strabismus surgery with prophylactically administered Droperidol or ondansetron hydrochloride.

Methods:

A double-masked, randomized, prospective study was conducted comparing droperidol with ondansetron hydrochloride when administered prophylactically to adults undergoing strabismus surgery.

Results:

Forty-five patients entered the study with a mean age of 30 years. Twenty percent of patients had nausea immediately postoperatively and 37% had nausea before discharge with no significant differences between groups. Overall rate of emesis, time in the recovery room, and time to discharge was not significantly different between the droperidol and ondansetron hydrochloride group.

Conclusion:

No real differences in the ability to prevent PONV between the two medications were found in this study.

Related Concept Videos

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

Chemotherapy-Induced Nausea and Vomiting: 5-HT₃ Receptor Antagonists

5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...

Ophthalmic Drug Delivery Systems

Ophthalmic Drug Delivery Systems

Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...

Articles linked to this work by shared authors, journal, and citation graph.

The autogenous dermis-fat orbital implant in children.

Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus·2001

Magnetic resonance imaging in ophthalmoplegic migraine of children.

Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus·2001

Long-term surgical outcomes of patients with glaucoma secondary to the iridocorneal endothelial syndrome.

Ophthalmology·2001

Late onset lens particle glaucoma as a consequence of spontaneous dislocation of an intraocular lens in pseudoexfoliation syndrome.

American journal of ophthalmology·2001

Selective omission of the donor cross-match before renal transplantation: efficacy, safety and effects on cold storage time.

Transplantation·2001

Childhood and adolescent predictors of schizophrenia in the Northern Finland 1966 birth cohort--a descriptive life-span model.

European archives of psychiatry and clinical neuroscience·2001

See all related articles